您的购物车当前为空
JNJ-64264681为一种高效的口服可活性选择性不可逆共价BTK抑制剂,展现出优良的药物代谢动力学属性,适用于癌症与自身免疫性疾病领域研究。

JNJ-64264681为一种高效的口服可活性选择性不可逆共价BTK抑制剂,展现出优良的药物代谢动力学属性,适用于癌症与自身免疫性疾病领域研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 6-8周 | |
| 50 mg | ¥ 13,800 | 6-8周 | |
| 100 mg | ¥ 17,500 | 6-8周 |
JNJ-64264681 相关产品
| 产品描述 | JNJ-64264681 is a potent, orally active, selective, and irreversible covalent inhibitor of Bruton's tyrosine kinase (BTK). This compound demonstrates favorable pharmacokinetic properties and is applicable in the research of cancer and autoimmune diseases [1]. |
| 分子量 | 518.63 |
| 分子式 | C27H30N6O3S |
| CAS No. | 2101524-34-7 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容